• -
14 Results
Marijuana medical oil.
Texas Hemp Is Booming: Protect Consumers via Regulation
From 2020 to 2023, sales of hemp-derived cannabinoids increased by 1,283%, reaching a value of $2.78 billion last year. Although the Texas hemp industry is booming, lack of regulation poses risks to public health. A new brief from the Drug Policy Program makes specific recommendations for strengthening and enforcing current laws — ensuring consumer safety while also providing economic benefits for the state.
Drug Policy Program May 31, 2024
Woman browsing
From Neuroweapons to ‘Neuroshields’: Safeguarding Brain Capital for National Security
This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick Love August 10, 2023
A nurse administers a COVID-19 vaccination.
Failures in COVID-19 Vaccine Administration Data Collection Complicated Efforts to Ensure Vaccine Equity in Texas
As the pandemic persisted across the state, did Texans living in cities have better access to Covid-19 vaccines than those in rural areas? How did race or age factor in? The authors assess the successes and shortfalls of Texas' vaccine distribution strategy, and how to do better next time.
Kirstin R.W. Matthews, Rekha Lakshmanan March 4, 2022
Unbalanced scales of justice.
Drug Policy Priority Issues for the Biden Administration
Effective drug policy requires acceptance that, for better or worse, licit and illicit drug use is part of our world. The authors recommend several steps the federal government can take to facilitate more pragmatic and effective drug policy at all levels of government.
Katharine Neill Harris, William Martin February 5, 2021